ASSESSING THE INCREMENTAL PREDICTIVE VALUE OF MARKERS: UNDERSTANDING MODERN RECLASSIFICATION MEASURES BY A NEW GRAPHICAL DISPLAY

Tuesday, October 22, 2013
Key Ballroom Foyer (Hilton Baltimore)
Poster Board # P3-27
Quantitative Methods and Theoretical Developments (MET)

Ewout W. Steyerberg, PhD, Department of Public Health, AE 236, Rotterdam, Netherlands, Moniek Vedder, MSc, Erasmus MC, Rotterdam, Netherlands, Douwe Postmus, PhD, University Medical Center Groningen, Groningen, Netherlands, Michael Pencina, PhD, Duke University, Durham, NC and Ben Van Calster, PhD, Katholieke Universiteit Leuven, Leuven, Belgium

Purpose To review measures and graphical displays to assess the incremental predictive value of markers over standard, readily available characteristics.
Methods We evaluate the incremental value of adding HDL to a Cox regression model in 3264 subjects from the Framingham study to predict 10-year risk of coronary heart disease (n=183 events, Pencina Stat Med 2008). Statin therapy is considered indicated for subjects with higher than 20% 10-year risks.

   A traditional measure for incremental values is the improvement in the area under the ROC curve (AUC). New measures include the net reclassification improvement (NRI) and decision-analytic measures, such as the net benefit (NB).
Results The AUC difference (ΔAUC) between a model with and without HDL was small in numerical value (0.012 for adding HDL with continuous risk; 0.029 with 20% threshold). Using a 20% threshold to classifiy subjects as high risk, the 2 NRI components are the net percentages of correctly reclassified patients with events (11/183=6.0%) and without events (-5/3081=-0.2%). Their sum is the NRI (0.058, which is higher in numerical value than ΔAUC, 0.029).

   The NB is the net fraction of true-positive (TP) classifications penalized for false-positive (FP) classifications: NB= (TP - w FP)/N, with w defined by the odds of harms:benefits, or odds(threshold). A threshold of 20% implies w=0.2/(1-0.2)=0.25. ΔNB can hence be calculated as (11 – 0.25*5)/3264=0.30%.

   For better understanding of the NRI and NB, we propose a "Net Reclassification Risk" graph. This simple graph allows us to focus on the number of patients and event rates of the 2 reclassified groups: those reclassified from high to low risk (H/L, n=29, 10% event rate) and those reclassified from low to high risk (L/H, n=45, 31% event rate). We note that 45*0.31 – 29*0.10 = 11 events can be extra identified (ΔTP=11, NRIevents 11/183, 6%). The negative side is that 45*(1-0.31) – 29*(1-0.10) = 5 extra overtreatments are expected (ΔFP=-5, NRInonevents -5/3081, -0.2%). The burden of overtreatment is explicitly weighted by 0.25 in the NB calculation, leading to the 0.30% estimate for NB ((11-1.25)/3264=0.30%).
Conclusions More modern and decision-analytic reclassiifcation measures can be better understood to assess the incremental predictive value of a marker by a simple graph for the Net Reclassification Risk ('NRR graph').

Description: et Reclassification Risk graph